at www.tipranks.com (Mon, 23-Mar 8:10 AM)
at www.tipranks.com (Mon, 23-Mar 8:01 AM)
Stifel Nicolaus Remains a Buy on Spyre Therapeutics (SYRE)
at www.tipranks.com (Sun, 22-Mar 1:35 PM)
Spyre Therapeutics (SYRE) Receives a Rating Update from a Top Analyst
at www.tipranks.com (Sat, 21-Mar 10:55 AM)
Spyre Therapeutics Completes First-in-Human Study of SPY001-001, De-risking Early Pipeline
at www.tipranks.com (Fri, 20-Mar 12:30 PM)